Argonne National Laboratory with the National Nuclear Security Admiration's (NNSA) Material Minimization and Management program (M 3 ), in partnership with SHINE Medical Technologies are developing technologies for the domestic production of 99 Mo. SHINE is planning to produce 99 Mo by fission of low enriched uranium (LEU) in a subcritical aqueous solution using accelerator-based neutron generation. In support of this goal, irradiations at Argonne's Van-deGraaff facility simulating LINAC irradiations were performed. The LEUModified Cintichem process has been chosen by SHINE to process their irradiated solutions. However, Cintichem rarely processed more than 1000 Ci of 99 Mo in a single batch. A concern is the Mo-ABO complex will break down under high dose conditions, causing a decrease in the recovery of 99 Mo. Irradiations of the Mo-ABO solid have been performed and the results will be discussed.
